<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://col.alphagenics.co/blog/col-acido-hialuronico-falsificado-invima-alerta-208-2026/</loc><news:news><news:publication><news:name>Alphagenics Colombia</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-12</news:publication_date><news:title>Ácido hialurónico falsificado en Colombia: alerta 208-2026 del Invima</news:title></news:news></url><url><loc>https://col.alphagenics.co/blog/col-cosmeticos-inyectables-invima-alerta-274-2025-nso/</loc><news:news><news:publication><news:name>Alphagenics Colombia</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-12</news:publication_date><news:title>Cosméticos «inyectables» en Colombia: alerta 274-2025 del Invima</news:title></news:news></url><url><loc>https://col.alphagenics.co/blog/col-pl-187-2026-poliza-complicaciones-medicina-estetica-colombia/</loc><news:news><news:publication><news:name>Alphagenics Colombia</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-12</news:publication_date><news:title>Colombia: PL 187 de 2026 exige reserva médica y póliza en estética</news:title></news:news></url><url><loc>https://col.alphagenics.co/blog/col-pl-367-obesidad-enfermedad-cronica-glp1-acceso/</loc><news:news><news:publication><news:name>Alphagenics Colombia</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-12</news:publication_date><news:title>Ley de obesidad en Colombia: qué cambia para el médico que prescribe GLP-1</news:title></news:news></url><url><loc>https://col.alphagenics.co/blog/col-colageno-hidrolizado-invima-alertas-ensayos/</loc><news:news><news:publication><news:name>Alphagenics Colombia</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-11</news:publication_date><news:title>Colágeno hidrolizado en Colombia: ensayos y alertas del Invima</news:title></news:news></url><url><loc>https://col.alphagenics.co/blog/col-fda-naion-glp1-advertencia-invima-colombia/</loc><news:news><news:publication><news:name>Alphagenics Colombia</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-11</news:publication_date><news:title>FDA y NAION: advertencia en todos los GLP-1 y qué pasa en Colombia</news:title></news:news></url><url><loc>https://col.alphagenics.co/blog/col-mounjaro-registro-diabetes-tirzepatida-sin-registro-vacio/</loc><news:news><news:publication><news:name>Alphagenics Colombia</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-11</news:publication_date><news:title>Mounjaro solo para diabetes y tirzepatida sin registro en Colombia</news:title></news:news></url><url><loc>https://col.alphagenics.co/blog/col-nad-inyectable-invima-alerta-181-2026-evidencia-humanos/</loc><news:news><news:publication><news:name>Alphagenics Colombia</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-11</news:publication_date><news:title>NAD+ inyectable en Colombia: alerta 181-2026 y la evidencia humana</news:title></news:news></url></urlset>
